Company / Free Cash Flow
LivaNova Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$173.3M
FY2025
5-year range
-$115.8M / $173.3M
FY2021-FY2025
Trend
+27.5%
vs FY2024
Sector context
#71 of 151
Health Care
What the data says
At $173M, LivaNova's free cash flow ranks #71 of 151 in the Health Care sector. Free Cash Flow has increased for 4 consecutive years, from -$116M in FY2021 to $173M in FY2025.
Based on SEC 10-K filings.
$173M in FY2025.
Improved from $40M to $173M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#71 of 151 in Health CareTop 47% of 151This company $173.3M Sector average $779.8M
▼
-77.8% below sector average
Key checks
Key Insights
- LivaNova's free cash flow has grown for 4 consecutive years.
- In FY2025, free cash flow increased 27.5% year-over-year.
- Ranks #71 out of 151 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $173.3M | +27.5% |
| FY2024 | $135.9M | +240.4% |
| FY2023 | $39.9M | +134.9% |
| FY2022 | -$114.4M | +1.2% |
| FY2021 | -$115.8M | -1.2% |
| FY2020 | -$114.4M | +1.2% |
| FY2019 | -$115.8M | -239.1% |
| FY2018 | $83.3M | +42.6% |
| FY2017 | $58.4M | +12.8% |
| FY2016 | $51.8M | +294.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026